SEATTLE (AP) _ Adaptive Biotechnologies Corp. (ADPT) on Wednesday reported a loss of $62.7 million in its first quarter.The Seattle-based company said it had a loss of 44 cents per share.The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share.The life-sciences research company posted revenue of $38.6 million in the period, which also fell short of Street forecasts. Four analysts surveyed by Zacks expected $38.7 million.Adaptive Biotechnologies expects full-year revenue in the range of $185 million to $195 million.Adaptive Biotechnologies shares have decreased 67% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $9.25, a fall of 75% in the last 12 months._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADPT at https://www.zacks.com/ap/ADPT